Two medications, liraglutide and insulin, were better at keeping A1C (a measurement of average blood glucose) levels less than 7% in recent GRADE study. The UNC Diabetes Care Center, lead by site principal investigator Sue Kirkman, MD, professor of medicine, in the division of endocrinology and metabolism, was one of the 37 sites to be a part of this NIH-funded comparative effectiveness study.
Read more from the UNC Health and UNC School of Medicine Newsroom.